Bernd Voedisch

Lab Head R & D at Novartis

Dr. Bernd Voedisch studied Biotechnology at Braunschweig University of Technology in Braunschweig, Germany. He did his PhD in the field of recombinant antibody technologies and then joined the Novartis Institutes for Biomedical Research (NIBR) in Basel, Switzerland, as a PostDoc. He stayed at Novartis as a lab head in the Biologics protein production platform, providing project teams with proteins and recombinant cell lines enabling discovery and characterization of various therapeutic protein classes (i.e., antibodies, multi-specifics, and non-antibody therapeutic proteins). He then switched to the cell line development unit where his additional responsibilities include the early assessment of Biologics candidates in the CHO expression system and generation of monoclonal CHO cell lines for Biologics manufacturing for clinical and market supply.